glp-1 and alzheimer's Neuroprotective Actions of Glucagon-Like Peptide-1 (GLP-1) Analogues in Parkinson's Diseases | CNS Drugs GLP-1 Receptor Agonists in Neurodegeneration:

Experiments in mice indicate that stimulation of GLP1 receptors in the VTA weakens the synaptic strength of VTANAc projections (Wang et al., 2015), but relatively few VTA neurons express GLP1 receptors (Cork et al., 2015

Louwagie, MD, PhD, of the Department of Internal Medicine at LewisGale Hospital Montgomery in Blacksburg, Va

This potential reproductive efficacy explains the recent emphasis on clinical research and guidelines (83, 84)

According to Folek, obesity experts arent really sure how topiramate curbs hunger, but they think it works on brain chemicals to restrict the release of glutamate, another neurotransmitter that plays a role in appetite